(Q36429381)

14 August 2017

1 reference

title

Cancer biomarkers: knowing the present and predicting the future (English)

1 reference

14 August 2017

0 references

2

Bruce R Zetter

1 reference

14 August 2017

Sabarni K Chatterjee

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 August 2017

1 reference

14 August 2017

volume

1

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

37-50

1 reference

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Specific carcinoembryonic antigens of the human digestive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Prostate cancer: detection, staging, and treatment of localized disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Prostate specific antigen only progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Urine based markers of urological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

The role of osteopontin in breast cancer: clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Diagnostic and prognostic markers for human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

How to use prognostic factors in axillary node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Role of osteopontin in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

HER-2 expression and cell proliferation: prognostic markers in patients with node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Clinical potential of proteomics in the diagnosis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Prognostic molecular markers in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Beta-2 microglobulin and lactate dehydrogenase levels are useful prognostic markers in early stage primary gastric lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Caspase-3 expression in human gastric carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

High density synthetic oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Light-directed, spatially addressable parallel chemical synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Serial analysis of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

ONCOMINE: a cancer microarray database and integrated data-mining platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

New approaches to proteomic analysis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Laser capture microdissection and advanced molecular analysis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

Prognostic significance ofc-myc andAIB1 amplification in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.37

21 January 2018

Identifiers

DOI

10.1517/14796694.1.1.37

1 reference

14 August 2017

1 reference